Truist lowered the firm’s price target on Molina Healthcare (MOH) to $370 from $400 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is key and cash flow generation with broadly attractive financial flexibility are set to provide solid support, while the recent valuation re-rating for several names provides a better setup around risk/reward, the analyst tells investors in a research note.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH:
- Tesla upgraded, MongoDB initiated: Wall Street’s top analyst calls
- Molina Healthcare assumed with Neutral from Overweight at JPMorgan
- Molina Healthcare Expands with New State Contracts
- Molina Healthcare awarded new contracts in Michigan, Idaho
- Lawmakers seek to break up PBMs from health insurers, WSJ reports
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
